Akso Health Group (AHG) — SEC Filings
Akso Health Group (AHG) — 11 SEC filings. Latest: 20-F (Aug 14, 2025). Includes 9 6-K, 2 20-F.
View Akso Health Group on SEC EDGAR
Overview
Akso Health Group (AHG) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 20-F filed on Aug 14, 2025: Akso Health Group (AHG) filed its 20-F for the fiscal year ended March 31, 2025, as a holding company incorporated in the Cayman Islands. The company conducts business through its U.S. and PRC subsidiaries, having previously utilized a variable interest entity (VIE) structure for its China operation
Sentiment Summary
Across 11 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 8 neutral, 1 mixed. The dominant filing sentiment for Akso Health Group is neutral.
Filing Type Overview
Akso Health Group (AHG) has filed 2 20-F, 9 6-K with the SEC between Jan 2024 to Aug 2025.
Filings by Year
Recent SEC Filings (11)
| Date | Form | Description | Risk |
|---|---|---|---|
| Aug 14, 2025 | 20-F | Akso Health Navigates PRC Regulatory Minefield in 20-F Filing | high |
| May 1, 2025 | 6-K | Akso Health Group Announces CFO Change | low |
| Mar 28, 2025 | 6-K | Akso Health Group Files 6-K for Sept 2024 Period | low |
| Nov 8, 2024 | 6-K | Akso Health Group Files 6-K Report | low |
| Jul 30, 2024 | 20-F | Akso Health Group Files 2024 Annual Report | medium |
| May 2, 2024 | 6-K | Akso Health Group Files 6-K on 2024 Annual Meeting Results | low |
| Mar 26, 2024 | 6-K | Akso Health Group Files 6-K Report | low |
| Mar 8, 2024 | 6-K | Akso Health Group Files 6-K on Direct Offering | medium |
| Jan 29, 2024 | 6-K | AKSO Closes $53.35M Private Placement, Issues 160.8M Shares & Warrants | |
| Jan 22, 2024 | 6-K | Akso Health Group Raises $53.35M in Private Placement for Working Capital | |
| Jan 3, 2024 | 6-K | Akso Health Files Interim Financials, Incorporates into Key Registrations |
Risk Profile
Risk Assessment: Of AHG's 8 recent filings, 1 were flagged as high-risk, 2 as medium-risk, and 5 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Zhongliang Xie
Industry Context
Akso Health Group operates within the healthcare sector, likely encompassing medical devices and services, in China. This industry is characterized by rapid technological advancements and a growing demand for healthcare solutions. However, it is also subject to stringent government regulations and evolving market dynamics, including increasing competition and price pressures.
Top Tags
foreign-private-issuer (3) · corporate-action (2) · regulatory-filing (2) · foreign-issuer (2) · corporate-update (2) · private-placement (2) · capital-raise (2) · China Regulation (1) · VIE Structure (1) · Cybersecurity Risk (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Ordinary shares outstanding | 1,655,583,530 | As of March 31, 2025, re-designated into Class A and Class B ordinary shares on April 30, 2024. |
| Par value per share | US$0.0001 | Par value for both Class A and Class B ordinary shares. |
| Exchange rate to US$1.00 | RMB 7.2567 | Used for financial translations as of March 31, 2025. |
| Ordinary shares per ADS | 3 | Each American depositary share represents three Class A ordinary shares. |
| Users threshold | 1,000,000 | Number of users whose personal data, if possessed by an online platform operator, triggers a cybersecurity review by the CAC. |
| Commission File Number | 001-38245 | Identifies the company's registration with the SEC. |
| Reporting Period End Date | 20240930 | Indicates the period covered by the financial information in the filing. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Akso Health Group (AHG)?
Akso Health Group has 11 recent SEC filings from Jan 2024 to Aug 2025, including 9 6-K, 2 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of AHG filings?
Across 11 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 8 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Akso Health Group SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Akso Health Group (AHG) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Akso Health Group?
Financial highlights for Akso Health Group are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for AHG?
The investment thesis for AHG includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Akso Health Group?
Key executives identified across Akso Health Group's filings include Zhongliang Xie.
What are the main risk factors for Akso Health Group stock?
Of AHG's 8 assessed filings, 1 were flagged high-risk, 2 medium-risk, and 5 low-risk.
What are recent predictions and forward guidance from Akso Health Group?
Forward guidance and predictions for Akso Health Group are extracted from SEC filings as they are enriched.